DK3247413T3 - Vævsmatricer med kontrolleret porøsitet eller mekaniske egenskaber - Google Patents

Vævsmatricer med kontrolleret porøsitet eller mekaniske egenskaber Download PDF

Info

Publication number
DK3247413T3
DK3247413T3 DK16703018.8T DK16703018T DK3247413T3 DK 3247413 T3 DK3247413 T3 DK 3247413T3 DK 16703018 T DK16703018 T DK 16703018T DK 3247413 T3 DK3247413 T3 DK 3247413T3
Authority
DK
Denmark
Prior art keywords
porousity
controlled
mechanical properties
matrixes
tissue
Prior art date
Application number
DK16703018.8T
Other languages
English (en)
Inventor
Israel Jessop
Mrinal Shah
Patrick Leamy
Original Assignee
Lifecell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifecell Corp filed Critical Lifecell Corp
Application granted granted Critical
Publication of DK3247413T3 publication Critical patent/DK3247413T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
DK16703018.8T 2015-01-21 2016-01-20 Vævsmatricer med kontrolleret porøsitet eller mekaniske egenskaber DK3247413T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562105971P 2015-01-21 2015-01-21
US201562148532P 2015-04-16 2015-04-16
PCT/US2016/014009 WO2016118558A1 (en) 2015-01-21 2016-01-20 Tissue matrices with controlled porosity or mechanical properties

Publications (1)

Publication Number Publication Date
DK3247413T3 true DK3247413T3 (da) 2021-03-01

Family

ID=55300794

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16703018.8T DK3247413T3 (da) 2015-01-21 2016-01-20 Vævsmatricer med kontrolleret porøsitet eller mekaniske egenskaber

Country Status (10)

Country Link
US (2) US20160206784A1 (da)
EP (2) EP3247413B1 (da)
JP (1) JP7307527B2 (da)
CN (1) CN107206125A (da)
AU (2) AU2016209422B2 (da)
CA (1) CA2974120A1 (da)
DK (1) DK3247413T3 (da)
ES (1) ES2857028T3 (da)
HK (1) HK1246212A1 (da)
WO (1) WO2016118558A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
EP4046667A1 (en) 2017-03-06 2022-08-24 Tei Biosciences, Inc. Perforated tissue graft
CN108404195A (zh) * 2018-04-22 2018-08-17 代清燕 一种抗菌性促皮肤伤口愈合敷料及其制备方法
KR101938263B1 (ko) * 2018-07-31 2019-01-14 강호창 치과용 이중구조 멤브레인의 제조방법
CN114366857A (zh) * 2022-02-08 2022-04-19 博纳格科技(天津)有限公司 一种可降解人工骨复合材料的制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US54A (en) 1836-10-15 Art of managing and supplying fie-e for generating steam in locomotive
US8735A (en) 1852-02-17 John oaed
US5709934A (en) * 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
IL123941A (en) * 1995-10-04 2001-08-26 Monsanto Co Porous polymeric biosupports and their use in the biotreatment of aqueous waste streams
JP4968976B2 (ja) * 1998-03-06 2012-07-04 慶彦 清水 コラーゲン材及びその製法
US6933326B1 (en) * 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
US20080286242A2 (en) * 1999-11-05 2008-11-20 Donald Kleinsek Augmentation and repair of spincter defects with cells including mesenchymal cells
US6599323B2 (en) * 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
CA2412012C (en) * 2001-11-20 2011-08-02 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Resorbable extracellular matrix containing collagen i and collagen ii for reconstruction of cartilage
US7597885B2 (en) * 2004-03-26 2009-10-06 Aderans Research Institute, Inc. Tissue engineered biomimetic hair follicle graft
JP2007177074A (ja) * 2005-12-28 2007-07-12 Tohoku Univ 組成物およびその製造方法
ES2720582T3 (es) * 2006-05-09 2019-07-23 Lifecell Corp Tejido biológico reforzado
GB2453452B (en) * 2006-05-16 2010-12-01 Purdue Research Foundation Three dimensional purified collagen matrices
US20100185219A1 (en) * 2007-04-25 2010-07-22 Musculosketetal Transplant Foundation Reinforced biological mesh for surgical reinforcement
CN100531808C (zh) * 2007-04-28 2009-08-26 徐志飞 可降解的软组织修补片
ES2714365T3 (es) * 2007-07-10 2019-05-28 Lifecell Corp Composiciones acelulares de matriz tisular para reparación de tejidos
US8735054B1 (en) 2008-01-04 2014-05-27 Lifecell Corporation Acellular tissue matrix preservation solution
ES2655281T3 (es) 2008-06-06 2018-02-19 Lifecell Corporation Tratamiento de elastasa de matrices tisulares
WO2010059783A2 (en) * 2008-11-21 2010-05-27 Lifecell Corporation Reinforced biologic material
EP2464724A4 (en) * 2009-08-11 2013-11-20 Univ Johns Hopkins COMPOSITIONS AND METHODS FOR IMPLANTATION OF TREATED ADIPOSE TISSUE AND TREATED ADIPOSE TISSUE PRODUCTS
EP2549957B1 (en) * 2010-03-23 2019-01-30 Edwards Lifesciences Corporation Methods of conditioning sheet bioprosthetic tissue
US8784499B2 (en) * 2010-03-25 2014-07-22 Lifecell Corporation Preparation of regenerative tissue scaffolds
DK2600910T3 (da) * 2010-08-05 2016-04-04 Lifebond Ltd Sårbandager og klæbemidler omfattende tørre sammensætninger
JP5963208B2 (ja) * 2010-08-10 2016-08-03 ライフセル コーポレーションＬｉｆｅＣｅｌｌ Ｃｏｒｐｏｒａｔｉｏｎ 再生組織足場
ES2874487T3 (es) * 2011-05-31 2021-11-05 Lifecell Corp Matrices de tejido adiposo
CA2885327A1 (en) * 2012-09-26 2014-04-03 Lifecell Corporation Processed adipose tissue
WO2014123703A1 (en) * 2013-02-06 2014-08-14 Lifecell Corporation Methods for localized modification of tissue products

Also Published As

Publication number Publication date
AU2016209422A1 (en) 2017-08-03
EP3795186A1 (en) 2021-03-24
AU2016209422B2 (en) 2020-04-16
JP7307527B2 (ja) 2023-07-12
US20160206784A1 (en) 2016-07-21
EP3247413A1 (en) 2017-11-29
HK1246212A1 (zh) 2018-09-07
AU2020204357A1 (en) 2020-07-16
WO2016118558A1 (en) 2016-07-28
CA2974120A1 (en) 2016-07-28
JP2018504206A (ja) 2018-02-15
US20230063323A1 (en) 2023-03-02
CN107206125A (zh) 2017-09-26
EP3247413B1 (en) 2020-11-25
ES2857028T3 (es) 2021-09-28

Similar Documents

Publication Publication Date Title
FIC20230006I1 (fi) Vutrisiraani
FIC20230014I1 (fi) Foslevodopa ja foskarbidopa
DK3354729T3 (da) Anti-garp-antistof
DK3623390T3 (da) Kulhydrattværbinder
DK3393537T3 (da) Biomedicinske materialer med høj styrke
DK3247413T3 (da) Vævsmatricer med kontrolleret porøsitet eller mekaniske egenskaber
DK3137168T3 (da) Substituerede 4-phenylpiperidiner, deres fremstilling og anvendelse
DK3265641T3 (da) Stigørenhed og fremgangsmåde
DK3393478T3 (da) Kombinationsterapi
DK3283041T3 (da) Collagenstimuleringsanordning
DE112015003841A5 (de) Di- und triphosphat-propharmaka
FR3059559B1 (fr) Descendeur autobloquant
EP3340951C0 (en) SURGICAL BANDAGE WITH STABILIZATION ELEMENTS
DK3325027T3 (da) Medicinsk implantat
BR112017026299A2 (pt) conjunto e embarcação
FI20145972A (fi) Potkurisekoitin
DK3331600T3 (da) Kateter
FI20145971A (fi) Potkurisekoitin
DE112016003063A5 (de) Verstellvorrichtung
DK3359102T3 (da) Medicinsk plaster
DE112015003744A5 (de) Gelenkwelle
FR3037492B1 (fr) Ustensile de cuisson
DK3319719T3 (da) Emulgatorblandinger
GB201515820D0 (en) Tissue engineering
ES1141057Y (es) Tejido